| Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Apr 23, 2021 |
Chief Medical Officer
Trans History: 12
|
Chief Medical Officer | Form 3/A | Amendment to an Initial Statement of Beneficial Ownership of Securities | 10,000 | -- | -- |
| Apr 23, 2021 |
Chief Medical Officer
Trans History: 12
|
Chief Medical Officer | Form 3/A | Amendment to an Initial Statement of Beneficial Ownership of Securities | 5,000 | -- | -- |
| Apr 23, 2021 |
Chief Medical Officer
Trans History: 12
|
Chief Medical Officer | Form 3/A | Amendment to an Initial Statement of Beneficial Ownership of Securities | 10,210 | -- | -- |
| Dec 30, 2021 |
Chief Informatics Officer
Trans History: 1
|
Chief Informatics Officer | Form 5 | Bona fide gift | 318,899 | -- | 5,006,479 |
| Aug 23, 2018 |
Chief Scientific Officer
Trans History: 21
|
Chief Scientific Officer | Form 4 | Conversion of derivative security | 5,941 | -- | 7,354 |
| Aug 23, 2018 |
Chief Scientific Officer
Trans History: 21
|
Chief Scientific Officer | Form 4 | Conversion of derivative security | 1,231 | -- | 8,585 |
| Aug 23, 2018 |
Chief Scientific Officer
Trans History: 21
|
Chief Scientific Officer | Form 4 | Conversion of derivative security | 101,918 | -- | 110,503 |
| Aug 23, 2018 |
Chief Scientific Officer
Trans History: 21
|
Chief Scientific Officer | Form 4 | Conversion of derivative security | 2,433 | -- | 112,936 |
| Aug 23, 2018 |
Chief Scientific Officer
Trans History: 21
|
Chief Scientific Officer | Form 4 | Conversion of derivative security | 254,275 | -- | -- |
| Aug 23, 2018 |
Chief Scientific Officer
Trans History: 21
|
Chief Scientific Officer | Form 4 | Conversion of derivative security | 52,720 | -- | -- |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.